Artemis Investment Management LLP Axogen, Inc. Transaction History

Artemis Investment Management LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 10, 2019	SELL	$12.09 - $20.46 $3.43 Million - $5.81 Million	-283,872 Closed	0 $0
Q2 2019 Jul 24, 2019	SELL	$18.5 - $25.47 $2.74 Million - $3.78 Million	-148,364 Reduced 34.32%	283,872 $5.47 Million
Q1 2019 May 15, 2019	SELL	$14.62 - $22.13 $2.82 Million - $4.26 Million	-192,705 Reduced 30.84%	432,236 $9.11 Million
Q4 2018 Feb 12, 2019	BUY	$17.09 - $38.25 $1.95 Million - $4.36 Million	114,048 Added 22.32%	624,941 $12.8 Million
Q3 2018 Nov 09, 2018	BUY	$34.05 - $55.9 $1.08 Million - $1.78 Million	31,757 Added 6.63%	510,893 $18.8 Million
Q2 2018 Aug 08, 2018	BUY	$36.15 - $52.5 $10.5 Million - $15.2 Million	290,254 Added 153.67%	479,136 $24.1 Million
Q1 2018 May 10, 2018	BUY	$24.4 - $40.25 $4.61 Million - $7.6 Million	188,882 New	188,882 $6.89 Million

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

Stay updated on Artemis Investment Management LLP with notifications on news.